Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy

Patients with prostate cancer (PCa) have a variable prognosis. It is challenging to recognize the progressive disease. In this study, we focused on TSPAN1, a new member of the tetraspanin family. Its expression was decreased in progressive PCa and was an independent prognosis factor of biochemical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fan, Gao, Yujing, Wang, Yanqing, Pan, Jiahua, Sha, Jianjun, Shao, Xiaoguang, Kang, Xunlei, Qin, Jun, You, M. James, Huang, Yiran, Dong, Baijun, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325364/
https://www.ncbi.nlm.nih.gov/pubmed/27556508
http://dx.doi.org/10.18632/oncotarget.11448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325364/
https://www.ncbi.nlm.nih.gov/pubmed/27556508
http://dx.doi.org/10.18632/oncotarget.11448

Ejemplares similares